Antimicrobial activity of sulfonamides containing 5-chloro-2- hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold

European Journal of Medicinal Chemistry

Volumn 50, Issue , 2012, Pages 433-440

  Krátký, Martin ^a   Vinšová, Jarmila ^a   Volková, Marie ^a   Buchta, Vladimír ^a,b   Trejtnar, František ^a   Stolaříková, Jiřina ^c  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

Author keywords

Antibacterial activity; Antimycobacterial activity; In vitro activity; Salicylanilide; Schiff base; Sulfonamide

Indexed keywords

3 CHLORO N [4 [4 (5 METHYLISOXAZOL 3 YL)SULFAMOYL]PHENYL]BENZAMIDE; 4 (3 CHLOROBENZYLIDENEAMINO) N (5 METHYLISOXAZOL 3 YL)BENZENESULFONAMIDE; 4 (5 CHLORO 2 HYDROXYBENZYLIDENEAMINO) N (4,6 DIMETHYLPYRIMIDIN 2 YL)BENZENESULFONAMIDE; 4 (5 CHLORO 2 HYDROXYBENZYLIDENEAMINO) N (5 METHYLISOXAZOL 3 YL)BENZENESULFONAMIDE; 4 (5 CHLORO 2 HYDROXYBENZYLIDENEAMINO) N (PYRIMIDIN 2 YL)BENZENESULFONAMIDE; 4 (5 CHLORO 2 HYDROXYBENZYLIDENEAMINO) N (THIAZOL 2 YL)BENZENESULFONAMIDE; 4 AMINO N (THIAZOL 2 YL)BENZENESULFONAMIDE; 5 CHLORO 2 HYDROXY N [4 (N PYRIMIDIN 2 YLSULFAMOYL)PHENYL]BENZAMIDE; 5 CHLORO 2 HYDROXY N [4 (N THIAZOL 2 YLSULFAMOYL)PHENYL]BENZAMIDE; 5 CHLORO 2 HYDROXY N [4 [N (5 METHYLISOXAZOL 3 YL)SULFAMOYL]PHENYL]BENZAMIDE; 5 CHLORO N [4 [N (4,6 DIMETHYLPYRIMIDIN 2 YL)SULFAMOYL]PHENYL] 2 HYDROXYBENZAMIDE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; BACITRACIN; HYDROXYALDEHYDE; HYDROXYBENZOIC ACID DERIVATIVE; ISONIAZID; SULFADIAZINE; SULFADIMIDINE; SULFAMETHOXAZOLE; SULFATHIAZOLE; SULFONAMIDE; UNCLASSIFIED DRUG;

ABSIDIA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS; ESCHERICHIA COLI; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOSPORON ASAHII;

ANTI-INFECTIVE AGENTS; BACTERIA; BENZAMIDES; FUNGI; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; THIAZOLES;

EID: 84858448335     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.01.060     Document Type: Article

References (39)

1. X.L. Wang, K. Wan, and C.H. Zhou Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities Eur. J. Med. Chem. 45 2010 4631 4639
2. M.E. Epstein, M. Amodio-Groton, and N.S. Sadick Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin J. Am. Acad. Dermatol. 37 1997 365 381
3. J.D. Smilack Trimethoprim-sulfamethoxazole Mayo Clin. Proc. 74 1999 730 734
4. P.A. Masters, T.A. O'Bryan, J. Zurlo, D.Q. Miller, and N. Joshi Trimethoprim-sulfamethoxazole revisited Arch. Intern. Med. 163 2003 402 410
5. O. Sköld Sulfonamide resistance: mechanisms and trends Drug Resist. Updates 3 2000 155 160
6. P. Forgacs, N.L. Wengenack, L. Hall, S.K. Zimmerman, M.L. Silverman, and G.D. Roberts Tuberculosis and trimethoprim-sulfamethoxazole Antimicrob. Agents Chemother. 53 2009 4789 4793
7. G.L. Woods Susceptibility testing for mycobacteria Clin. Infect. Dis. 31 2000 1209 1215
8. F. Carta, A. Maresca, A.S. Covarrubias, S.L. Mowbray, T.A. Jones, and C.T. Supuran Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c Bioorg. Med. Chem. Lett. 19 2009 6649 6654
9. F. Pacchiano, F. Carta, D. Vullo, A. Scozzafava, and C.T. Supuran Inhibition of beta-carbonic anhydrases with ureido-substituted benzenesulfonamides Bioorg. Med. Chem. Lett. 21 2011 102 105
10. W. Ong, A. Sievers, and D.E. Leslie Mycobacterium tuberculosis and sulfamethoxazole susceptibility Antimicrob. Agents Chemother. 54 2010 2748
11. K.E.A. Lougheed, D.L. Taylor, S.A. Osborne, J.S. Bryans, and R.S. Buxton New anti-tuberculosis agents amongst known drugs Tuberculosis 89 2009 364 370
12. L.C. Chio, L.A. Bolyard, M. Nasr, and S.F. Queener Identification of a class of sulfonamides highly active against dihydropteroate synthase from Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium Antimicrob. Agents Chemother. 40 1996 727 733
13. V.S. Georgiev Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections Int. J. Antimicrob. Agents 4 1994 247 270
14. W.J. Suling, L.E. Seitz, R.C. Reynolds, and W.W. Barrow New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors Antimicrob. Agents Chemother. 49 2005 4801 4803
15. W.V. Raszka, L.P. Skillman, and P.L. McEvoy In vitro susceptibility of clinical isolates of Mycobacterium avium and Mycobacterium intracellulare to folate antagonists Diagn. Microbiol. Infect. Dis. 18 1994 201 204
16. R.J. Wallace, K. Wiss, M.B. Bushby, and D.C. Hollowell In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria Rev. Infect. Dis. 4 1982 326 331
17. C.E. Davis Jr., J.L. Carpenter, S. Trevino, J. Koch, and A.J. Ognibene In vitro susceptibility of Mycobacterium avium complex to antibacterial agents Diagn. Microbiol. Infect. Dis. 8 1987 149 155
18. L. Shi, H.M. Ge, S.H. Tan, H.Q. Li, Y.C. Song, H.L. Zhu, and R.X. Tan Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde Eur. J. Med. Chem. 42 2007 558 564
19. J.-B. Tommasino, F.N.R. Renaud, D. Luneau, and G. Pilet Multi-biofunctional complexes combining antiseptic copper(II) with antibiotic sulfonamide ligands: structural, redox and antibacterial study Polyhedron 30 2011 1663 1670
20. C.D. Sheela, C. Anitha, P. Tharmaraj, and D. Kodimunthri Synthesis, spectral characterization, and antimicrobial studies of metal complexes of the Schiff base derived from [4-amino-N-guanylbenzene sulfonamide] and salicylaldehyde J. Coord. Chem. 63 2010 884 893
21. K.Y. El-Baradie Preparation and characterization of sulfadiazine Schiff base complexes of Co(II), Ni(II), Cu(II), and Mn(II) Monatsh. Chem. 136 2005 1139 1155
22. Z.H. Chohan, H.A. Shad, M.H. Youssoufi, and T.B. Hadda Some new biologically active metal-based sulfonamide Eur. J. Med. Chem. 45 2010 2893 2901
23. G.G. Mohamed, and C.M. Sharaby Metal complexes of Schiff base derived from sulphametrole and o-vanilin. Synthesis, spectral, thermal characterization and biological activity Spectrochim. Acta A 66 2007 949 958
24. M.S. Iqbal, A.H. Khan, B.A. Loothar, and I.H. Bukhari Effect of derivatization of sulfamethoxazole and trimethoprim with copper and zinc on their medicinal value Med. Chem. Res. 18 2009 31 42
25. Z.H. Chohan, M. Ul-Hassan, K.M. Khan, and C.T. Supuran In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff's bases and their metal complexes J. Enzym. Inhib. Med. Chem. 20 2005 183 188
26. Z.H. Chohan, and H.A. Shad Sulfonamide-derived compounds and their transition metal complexes: synthesis, biological evaluation and X-ray structure of 4-bromo-2-[(E)-{4-[(3,4-dimethylisoxazol-5 yl)sulfamoyl]phenyl} iminiomethyl] phenolate Appl. Organometal. Chem. 25 2011 591 600
27. K. Waisser, O. Bureš, P. Holý, J. Kuneš, R. Oswald, L. Jirásková, M. Pour, V. Klimešová, L. Kubicová, and J. Kaustová Relationship between the structure and antimycobacterial activity of substituted salicylanilides Arch. Pharm. Pharm. Med. Chem. 1 2003 53 71
28. M. Krátký, J. Vinšová, V. Buchta, K. Horvati, S. Bösze, and J. Stolaříková New amino acid esters of salicylanilides active against MDR-TB and other microbes Eur. J. Med. Chem. 45 2010 6106 6113
29. A. Imramovský, J. Vinšová, J.M. Férriz, R. Doležal, J. Jampílek, J. Kaustová, and F. Kunc New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains Bioorg. Med. Chem. 17 2009 3572 3579
30. J.M. Férriz, K. Vávrová, F. Kunc, A. Imramovský, J. Stolaříková, E. Vavří ková, and J. Vinšová Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains Bioorg. Med. Chem. 18 2010 1054 1061
31. C. Gelmetti Local antibiotics in dermatology Dermatol. Ther. 21 2008 187 195
32. R.A. Proctor Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection Clin. Infect. Dis. 46 2008 584 593
33. F.R. DeLeo, M. Otto, B.N. Kreiswirth, and H.F. Chambers Community-associated meticillin-resistant Staphylococcus aureus Lancet 375 2010 1557 1568
34. T. Tsukamoto, and K. Yuhi Studies on halogenosalicylaldehyde. I. Halogenosalicylaldehyde as reagent for primary amines Yakugaku Zasshi 78 1958 706 709
35. J. Kaustová Quantitative micromethod for drug susceptibility testing of mycobacteria in Šulás medium Klin. Microbiol. Inf. Lek. 3 1997 115 124
36. Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Growth Aerobically; Approved Standard - seventh ed. http://www.clsi.org/source/orders/free/m11a7.pdf (Accessed September 23, 2011).
37. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard - second ed. http://www.clsi.org/source/orders/free/M38-a2.pdf (Accessed September 23, 2011).
38. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - third ed. http://www.clsi.org/source/orders/free/M27-A3.pdf (Accessed September 23, 2011).
39. ® AQueous one solution cell Proliferation assay. US Patent Office, Pat. No. 5,185,450.